Your browser is no longer supported. Please, upgrade your browser.
Settings
XBIT XBiotech Inc. daily Stock Chart
XBIT [NASD]
XBiotech Inc.
Index- P/E- EPS (ttm)-1.63 Insider Own7.23% Shs Outstand37.15M Perf Week-6.68%
Market Cap290.51M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float16.64M Perf Month-28.13%
Income-53.10M PEG- EPS next Q-0.46 Inst Own17.10% Short Float27.05% Perf Quarter-40.80%
Sales- P/S- EPS this Y-33.80% Inst Trans2.27% Short Ratio25.05 Perf Half Y-49.02%
Book/sh2.47 P/B3.17 EPS next Y- ROA-65.10% Target Price13.00 Perf Year-44.22%
Cash/sh1.47 P/C5.32 EPS next 5Y- ROE-71.80% 52W Range7.71 - 25.00 Perf YTD-22.73%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-68.72% Beta-
Dividend %- Quick Ratio10.70 Sales past 5Y- Gross Margin- 52W Low1.43% ATR0.80
Employees103 Current Ratio10.70 Sales Q/Q- Oper. Margin- RSI (14)20.07 Volatility6.22% 6.68%
OptionableYes Debt/Eq0.00 EPS Q/Q0.10% Profit Margin- Rel Volume0.36 Prev Close8.07
ShortableYes LT Debt/Eq0.00 EarningsMay 04 BMO Payout- Avg Volume179.72K Price7.82
Recom3.00 SMA20-16.54% SMA50-40.53% SMA200-40.21% Volume64,262 Change-3.10%
Apr-21-17Downgrade Noble Financial Buy → Hold $13
Jun-28-16Reiterated Noble Financial Buy $24 → $30
May-19-17 09:16AM  Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme TheStreet.com
May-16-17 05:22PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT PR Newswire
May-11-17 08:31AM  XBiotech No. 2 Executive Resigns, Leaving Struggling Biotech Without Top Operations Chief TheStreet.com -9.70%
May-10-17 05:22PM  Edited Transcript of XBIT earnings conference call or presentation 4-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-04-17 08:00AM  Investor Network: XBiotech, Inc. to Host Earnings Call Accesswire
May-03-17 07:16PM  Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC. PR Newswire
Apr-28-17 08:01AM  XBiotech to Provide First Quarter 2017 Business Update GlobeNewswire
Apr-21-17 05:48PM  XBIOTECH NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In XBiotech, Inc. To Contact The Firm PR Newswire -39.89%
03:52PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. Business Wire
02:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT PR Newswire
02:06PM  Why XBiotech Inc. Got Crushed Today Motley Fool
09:45AM  XBiotech Stock Crumbles Following Disappointing EMA Meeting 24/7 Wall St.
09:34AM  Biotech Movers: XBiotech, Atara, Bellicum TheStreet.com
08:00AM  XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection TheStreet.com
Apr-20-17 06:57PM  XBiotech Announces Outcome of EMA's Oral Explanation Meeting GlobeNewswire
Apr-10-17 10:42AM  XBiotech Announces Additions To Its Scientific Advisory Board GlobeNewswire
10:33AM  XBiotech Announces Additions To Its Scientific Advisory Board GlobeNewswire
Apr-03-17 12:45PM  XBiotech: Four Staph Patients Died in Our Clinical Trial, Nothing to Worry About TheStreet.com
12:45PM  [video]XBiotech: Four Staph Patients Died in Our Clinical Trial, Nothing to Worry About
08:02AM  XBiotech Announces Top-Line Results for 514G3 Antibody Therapy in Serious Staphylococcus aureus Infections GlobeNewswire
08:00AM  XBiotech Announces Top-Line Results for 514G3 Antibody Therapy in Serious Staphylococcus aureus Infections GlobeNewswire
Mar-27-17 01:26PM  XBiotech Announces On-Time Submission to the EMA GlobeNewswire
01:18PM  XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes TheStreet.com
01:18PM  XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
01:11PM  XBiotech Announces On-Time Submission to the EMA GlobeNewswire
Mar-23-17 01:04PM  XBIOTECH INC. Financials
08:15AM  XBiotech (XBIT) Catches Eye: Stock Moves Up 11.6% in Session Zacks
08:02AM  XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory Board GlobeNewswire
08:00AM  XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory Board GlobeNewswire
Mar-17-17 05:26PM  Edited Transcript of XBIT earnings conference call or presentation 16-Mar-17 12:30pm GMT Thomson Reuters StreetEvents
Mar-16-17 04:13PM  XBIOTECH INC. Files SEC form 10-K, Annual Report +6.47%
08:30AM  XBiotech Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 XBiotech Inc Earnings Release - Before Market Open
Mar-09-17 08:02AM  XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update GlobeNewswire
08:00AM  XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update GlobeNewswire
Mar-03-17 03:39PM  XBIOTECH INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta +8.56%
09:28AM  XBiotech Announces Registered Direct Offering of Common Shares GlobeNewswire
09:17AM  XBiotech Announces Registered Direct Offering of Common Shares GlobeNewswire
Feb-22-17 08:01AM  XBiotech Completes Dosing of Subjects in PK Study Being Conducted in Connection with European Marketing Application GlobeNewswire
08:00AM  XBiotech Completes Dosing of Subjects in PK Study Being Conducted in Connection with European Marketing Application GlobeNewswire
Feb-21-17 08:02AM  XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study GlobeNewswire
08:00AM  XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study GlobeNewswire
Feb-16-17 11:34AM  XBiotech Meets Primary Endpoint in Phase 2 Study of MABp1 for Treatment of Hidradenitis Suppurativa (HS) GlobeNewswire
11:19AM  XBiotech Meets Primary Endpoint in Phase 2 Study of MABp1 for Treatment of Hidradenitis Suppurativa (HS) GlobeNewswire
Feb-08-17 11:20AM  XBIOTECH INC. Files SEC form 8-K, Other Events
Jan-17-17 08:02AM  XBiotech Phase 3 Data for Colorectal Cancer Therapy is Published in The Lancet Oncology GlobeNewswire
08:00AM  XBiotech Phase 3 Data for Colorectal Cancer Therapy is Published in The Lancet Oncology GlobeNewswire
Dec-20-16 04:20PM  European regulators raise questions about Austin drugmaker's lead cancer treatment at bizjournals.com
08:15AM  Blog Coverage Gilead Sciences Received Japanese Approval for its Hepatitis B Drug Accesswire
Dec-16-16 12:49PM  XBIOTECH INC. Files SEC form 8-K, Other Events -22.21%
Dec-07-16 08:02AM  XBiotech Completes Enrollment in Global Phase III Study using Xilonix Monotherapy to Treat Advanced Colorectal Cancer GlobeNewswire
08:00AM  XBiotech Completes Enrollment in Global Phase III Study using Xilonix Monotherapy to Treat Advanced Colorectal Cancer GlobeNewswire
Dec-06-16 08:02AM  XBiotech Completes Enrollment in Global Phase I/II Study for its True Human(TM) Antibody Treatment for Serious Staphylococcus aureus Infections GlobeNewswire
08:00AM  XBiotech Completes Enrollment in Global Phase I/II Study for its True Human Antibody Treatment for Serious Staphylococcus aureus Infections GlobeNewswire
Dec-05-16 04:01PM  XBIOTECH INC. Files SEC form 8-K, Other Events
10:08AM  XBiotech (XBIT): Strong Industry, Solid Earnings Estimate Revisions
Nov-28-16 02:23PM  XBiotech, Inc. :XBIT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
Nov-20-16 09:10PM  Edited Transcript of XBIT earnings conference call or presentation 15-Nov-16 1:30pm GMT
Nov-17-16 08:02AM  XBiotech Announces Research Collaboration with Renowned Gastroenterologist GlobeNewswire +6.29%
08:00AM  XBiotech Announces Research Collaboration with Renowned Gastroenterologist GlobeNewswire
Nov-15-16 09:21AM  XBiotech reports 3Q loss +7.58%
08:30AM  XBiotech Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q3 2016 XBiotech Inc Earnings Release - Before Market Open
Nov-14-16 03:34PM  XBIOTECH INC. Files SEC form 10-Q, Quarterly Report
Nov-10-16 08:00AM  XBiotech to Provide Third Quarter 2016 Business Update on November 15 GlobeNewswire
07:14AM  Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH
Oct-12-16 09:14AM  XBiotech Announces Successful Completion of EMA GMP Inspection GlobeNewswire
09:10AM  XBiotech Announces Successful Completion of EMA GMP Inspection GlobeNewswire
Oct-11-16 08:02AM  XBiotech Announces Dismissal of Class Action Lawsuit in Texas GlobeNewswire
08:00AM  XBiotech Announces Dismissal of Class Action Lawsuit in Texas GlobeNewswire
Sep-26-16 05:22PM  XBIOTECH INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Sep-13-16 03:27PM  XBiotech, Inc. :XBIT-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-07-16 09:46AM  What Makes XBiotech (XBIT) a Strong Sell?
Aug-22-16 03:06PM  XBiotech Announces Grand Opening Date for New Commercial Manufacturing Facility GlobeNewswire
03:05PM  XBiotech Announces Grand Opening Date for New Commercial Manufacturing Facility GlobeNewswire
Aug-16-16 09:12AM  Edited Transcript of XBIT earnings conference call or presentation 16-Aug-16 12:30pm GMT +5.05%
08:30AM  XBiotech Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q2 2016 XBiotech Inc Earnings Release - Before Market Open
Aug-12-16 05:28PM  XBIOTECH INC. Files SEC form 10-Q, Quarterly Report
Aug-10-16 08:02AM  XBiotech to Provide Second Quarter 2016 Business Update on August 16 GlobeNewswire
08:00AM  XBiotech to Provide Second Quarter 2016 Business Update on August 16 GlobeNewswire
Jul-26-16 02:42PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of XBiotech, Inc. - XBIT PR Newswire
Jul-22-16 06:47PM  XBiotech Provides Update on Xilonix(TM) Phase III Programs in US and EU GlobeNewswire
06:45PM  XBiotech Provides Update on Xilonix Phase III Programs in US and EU GlobeNewswire
Jul-18-16 12:37PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of XBiotech, Inc. Business Wire
Jul-14-16 10:18PM  XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group -15.49%
Jul-06-16 12:28PM  Coverage of Industry Leaders for Today -13.69%
Jul-05-16 05:37PM  Why XBiotech Inc. Fell 33% Today at Motley Fool -32.53%
12:19PM  Heres Why The XBiotech Inc (XBIT) Data Is So Important at Insider Monkey
12:00PM  XBiotech Plunges on Results of Colorectal Cancer Drug Trial
08:54AM  Coverage of Top Gainers Hertz Global, XBiotech, and Harley-Davidson
08:35AM  XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny
Jul-04-16 09:06AM  XBiotech Xilonix Positive in Phase III Colorectal Cancer Study
Jul-02-16 06:10AM  XBiotech Presents Pivotal Phase III Data Showing Xilonix Demonstrated Significant Clinical Response in Advanced Colorectal Cancer Patients Refractory to Further Treatment GlobeNewswire
Jul-01-16 05:19PM  5 Top Biotech Performers of 2016 +19.02%
Jun-28-16 08:40AM  XBiotech Signs Agreement With Megapharm To Market Xilonix In Israel GlobeNewswire
Jun-27-16 08:15AM  XBiotech (XBIT) Catches Eye: Stock Adds 5.6% in Session
Jun-21-16 11:27AM  XBIOTECH INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhib
Jun-14-16 08:17AM  XBiotech (XBIT): Moving Average Crossover Alert
Jun-10-16 09:18AM  Can The Uptrend Continue for XBiotech (XBIT)?
XBiotech Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company's lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer. It has also investigating its lead product candidate in various clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum, and hidradenitis suppurativa, as well as staphylococcus aureus infection, influenza, and clostridium difficile infection diseases. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIMARD JOHNChief Executive OfficerMay 24Option Exercise0.93240,000223,6086,393,267May 25 05:12 PM
HAN QUEENAVP Finance & HRNov 15Option Exercise0.7419,57314,48419,573Nov 17 04:01 PM
HAN QUEENAVP Finance & HRNov 15Sale15.0019,573293,5950Nov 17 04:01 PM